Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 1
2012 1
2013 2
2014 1
2015 3
2017 1
2019 1
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC, Kennedy GD, Lapi SE, Hartman YE, Richardson MT, Modi HM, Warram JM. Marston JC, et al. Among authors: hartman ye. J Surg Res. 2019 Jul;239:44-51. doi: 10.1016/j.jss.2019.01.065. Epub 2019 Feb 22. J Surg Res. 2019. PMID: 30798171 Free PMC article.
Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer.
Rosenthal EL, Moore LS, Tipirneni K, de Boer E, Stevens TM, Hartman YE, Carroll WR, Zinn KR, Warram JM. Rosenthal EL, et al. Among authors: hartman ye. Clin Cancer Res. 2017 Aug 15;23(16):4744-4752. doi: 10.1158/1078-0432.CCR-16-2968. Epub 2017 Apr 26. Clin Cancer Res. 2017. PMID: 28446503 Free PMC article. Clinical Trial.
In Vivo Fluorescence Immunohistochemistry: Localization of Fluorescently Labeled Cetuximab in Squamous Cell Carcinomas.
de Boer E, Warram JM, Tucker MD, Hartman YE, Moore LS, de Jong JS, Chung TK, Korb ML, Zinn KR, van Dam GM, Rosenthal EL, Brandwein-Gensler MS. de Boer E, et al. Among authors: hartman ye. Sci Rep. 2015 Jun 29;5:10169. doi: 10.1038/srep10169. Sci Rep. 2015. PMID: 26120042 Free PMC article.
Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer.
Korb ML, Hartman YE, Kovar J, Zinn KR, Bland KI, Rosenthal EL. Korb ML, et al. Among authors: hartman ye. J Surg Res. 2014 May 1;188(1):119-28. doi: 10.1016/j.jss.2013.11.1089. Epub 2013 Nov 22. J Surg Res. 2014. PMID: 24360117 Free PMC article.
Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.
Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, Strong TV, Schmalbach CE, Morlandt AB, Agarwal G, Hartman YE, Carroll WR, Richman JS, Clemons LK, Nabell LM, Zinn KR. Rosenthal EL, et al. Among authors: hartman ye. Clin Cancer Res. 2015 Aug 15;21(16):3658-66. doi: 10.1158/1078-0432.CCR-14-3284. Epub 2015 Apr 22. Clin Cancer Res. 2015. PMID: 25904751 Free PMC article. Clinical Trial.
Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.
Sweeny L, Liu Z, Lancaster W, Hart J, Hartman YE, Rosenthal EL. Sweeny L, et al. Among authors: hartman ye. Laryngoscope. 2012 Jul;122(7):1539-44. doi: 10.1002/lary.23266. Epub 2012 Mar 27. Laryngoscope. 2012. PMID: 22460537 Free PMC article.
A novel extracellular drug conjugate significantly inhibits head and neck squamous cell carcinoma.
Sweeny L, Hartman YE, Zinn KR, Prudent JR, Marshall DJ, Shekhani MS, Rosenthal EL. Sweeny L, et al. Among authors: hartman ye. Oral Oncol. 2013 Oct;49(10):991-7. doi: 10.1016/j.oraloncology.2013.07.006. Epub 2013 Aug 3. Oral Oncol. 2013. PMID: 23920309 Free PMC article.
Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet.
Kurundkar AR, Killingsworth CR, McIlwain RB, Timpa JG, Hartman YE, He D, Karnatak RK, Neel ML, Clancy JP, Anantharamaiah GM, Maheshwari A. Kurundkar AR, et al. Among authors: hartman ye. Pediatr Res. 2010 Aug;68(2):128-33. doi: 10.1203/PDR.0b013e3181e4c9f8. Pediatr Res. 2010. PMID: 20442689 Free PMC article.
Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.
Kim H, Hartman YE, Zhai G, Chung TK, Korb ML, Beasley TM, Zhou T, Rosenthal EL. Kim H, et al. Among authors: hartman ye. J Magn Reson Imaging. 2015 Oct;42(4):936-45. doi: 10.1002/jmri.24871. Epub 2015 Feb 20. J Magn Reson Imaging. 2015. PMID: 25704985 Free PMC article.
Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.
Liu Z, Hartman YE, Warram JM, Knowles JA, Sweeny L, Zhou T, Rosenthal EL. Liu Z, et al. Among authors: hartman ye. Mol Cancer Res. 2011 Aug;9(8):1008-17. doi: 10.1158/1541-7786.MCR-11-0043. Epub 2011 Jun 10. Mol Cancer Res. 2011. PMID: 21665938 Free PMC article.
12 results
Jump to page
Feedback